Yanqi Han

730 total citations
28 papers, 597 citations indexed

About

Yanqi Han is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Yanqi Han has authored 28 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Complementary and alternative medicine and 9 papers in Pharmacology. Recurrent topics in Yanqi Han's work include Natural product bioactivities and synthesis (9 papers), Traditional Chinese Medicine Analysis (8 papers) and Phytochemistry and Biological Activities (7 papers). Yanqi Han is often cited by papers focused on Natural product bioactivities and synthesis (9 papers), Traditional Chinese Medicine Analysis (8 papers) and Phytochemistry and Biological Activities (7 papers). Yanqi Han collaborates with scholars based in China, Zimbabwe and Macao. Yanqi Han's co-authors include Gang Bai, Min Jiang, Mengge Zhou, Guoan Luo, Yuanyuan Hou, Hongzhi Zhao, Zhang Tie-jun, Jun Xu, Changxiao Liu and Gang Bai and has published in prestigious journals such as PLoS ONE, Journal of Ethnopharmacology and BMC Genomics.

In The Last Decade

Yanqi Han

26 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanqi Han China 14 269 213 176 117 87 28 597
Xiang-Ri Li China 14 398 1.5× 136 0.6× 149 0.8× 123 1.1× 56 0.6× 50 677
Yuetao Liu China 20 574 2.1× 278 1.3× 261 1.5× 107 0.9× 67 0.8× 66 1.0k
Xu-Qin Shi China 17 443 1.6× 282 1.3× 204 1.2× 160 1.4× 44 0.5× 34 825
Qingtao Yu China 13 469 1.7× 330 1.5× 143 0.8× 206 1.8× 113 1.3× 21 723
Jiushi Liu China 13 424 1.6× 143 0.7× 106 0.6× 224 1.9× 56 0.6× 50 691
Wenhua Huang China 16 421 1.6× 156 0.7× 174 1.0× 192 1.6× 72 0.8× 48 878
Mingsong Fan China 14 293 1.1× 148 0.7× 88 0.5× 177 1.5× 43 0.5× 30 598
Lanzhen Zhang China 17 320 1.2× 167 0.8× 248 1.4× 184 1.6× 51 0.6× 39 793

Countries citing papers authored by Yanqi Han

Since Specialization
Citations

This map shows the geographic impact of Yanqi Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqi Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqi Han more than expected).

Fields of papers citing papers by Yanqi Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanqi Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqi Han. The network helps show where Yanqi Han may publish in the future.

Co-authorship network of co-authors of Yanqi Han

This figure shows the co-authorship network connecting the top 25 collaborators of Yanqi Han. A scholar is included among the top collaborators of Yanqi Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanqi Han. Yanqi Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Chuanjing, Kaixin Liu, Yanqi Han, et al.. (2025). Ginsenoside CK targets PHD2 to prevent platelet adhesion and enhance blood circulation by modifying the three-dimensional arrangement of collagen. Acta Pharmaceutica Sinica B. 15(3). 1497–1513.
3.
Liu, Wenjuan, Fukui Shen, Yanqi Han, et al.. (2024). Ligustilide covalently binds to Cys703 in the pre-S1 helix of TRPA1, blocking the opening of channel and relieving pain in rats with acute soft tissue injury. Journal of Ethnopharmacology. 330. 118217–118217. 3 indexed citations
4.
Han, Yanqi, Jun Xu, Qiang Zhu, et al.. (2023). Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection. Chinese Medicine. 18(1). 45–45. 1 indexed citations
5.
Shen, Fukui, Lei Wei, Yanqi Han, et al.. (2023). Ligustilide covalently binds to Cys129 of HMGCS1 to ameliorate dyslipidemia. Biomedicine & Pharmacotherapy. 166. 115323–115323. 7 indexed citations
6.
Wang, Chunfang, et al.. (2023). Natto: A medicinal and edible food with health function. Chinese Herbal Medicines. 15(3). 349–359. 16 indexed citations
8.
Han, Yanqi, et al.. (2018). Metabolomics Study of the Biochemical Changes in the Plasma of Myocardial Infarction Patients. Frontiers in Physiology. 9. 1017–1017. 20 indexed citations
9.
Zhang, Hongbing, Xin Wu, Jun Xu, et al.. (2018). The comparative pharmacokinetic study of Yuanhu Zhitong prescription based on five quality-markers. Phytomedicine. 44. 148–154. 20 indexed citations
10.
Cui, Qingxin, Yang Liu, Mengge Zhou, et al.. (2018). An Optimized MicroPET Imaging Method for the Distribution and Synergies of Natural Products. Frontiers in Pharmacology. 9. 948–948. 5 indexed citations
11.
Tie-jun, Zhang, Gang Bai, Yanqi Han, et al.. (2018). The method of quality marker research and quality evaluation of traditional Chinese medicine based on drug properties and effect characteristics. Phytomedicine. 44. 204–211. 69 indexed citations
12.
Tao, Zhengang, Yanqi Han, Mingming Xue, et al.. (2017). Therapeutic Mechanistic Studies of ShuFengJieDu Capsule in an Acute Lung Injury Animal Model Using Quantitative Proteomics Technology. Journal of Proteome Research. 16(11). 4009–4019. 41 indexed citations
13.
Li, Yanmei, Yanqi Han, Mengge Zhou, et al.. (2017). Anti-inflammatory effects of Shufengjiedu capsule for upper respiratory infection via the ERK pathway. Biomedicine & Pharmacotherapy. 94. 758–766. 40 indexed citations
14.
Sun, Dan, Yanqi Han, Weiya Wang, et al.. (2016). Screening and identification of Caulis Sinomenii bioactive ingredients with dual‐target NF‐κB inhibition and β2‐AR agonizing activities. Biomedical Chromatography. 30(11). 1843–1853. 22 indexed citations
15.
Li, Baiqing, Yanqi Han, Aina Liu, et al.. (2016). A rapid integrated bioactivity evaluation system based on near-infrared spectroscopy for quality control of Flos Chrysanthemi. Journal of Pharmaceutical and Biomedical Analysis. 131. 391–399. 42 indexed citations
16.
17.
Han, Yanqi, Mengge Zhou, Liqiang Wang, et al.. (2015). Comparative evaluation of different cultivars of Flos Chrysanthemi by an anti-inflammatory-based NF-κB reporter gene assay coupled to UPLC-Q/TOF MS with PCA and ANN. Journal of Ethnopharmacology. 174. 387–395. 57 indexed citations
18.
Jiang, Min, Yanqi Han, Mengge Zhou, et al.. (2014). The Screening Research of Anti-Inflammatory Bioactive Markers from Different Flowering Phases of Flos Lonicerae Japonicae. PLoS ONE. 9(5). e96214–e96214. 33 indexed citations
19.
Sun, Dan, Mengge Zhou, Bin‐Feng Cheng, et al.. (2014). Identification of nuclear factor-κB inhibitors in the folk herb Rhizoma Menispermi via bioactivity-based ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry analysis. BMC Complementary and Alternative Medicine. 14(1). 356–356. 8 indexed citations
20.
Jiang, Min, Mengge Zhou, Yanqi Han, et al.. (2013). Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF. Journal of Ethnopharmacology. 147(2). 426–433. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026